Revlon, Inc. Overview
Revlon is a 94-year-old American beauty house. Through a portfolio of more than 20 brands it makes and markets colour cosmetics, hair colour and care, fragrance, skin care, nail and personal-care products. Most of its volume goes through mass retail, led by Walmart, which accounted for ~14% of FY2022 sales. It also sells in prestige (Elizabeth Arden), professional salons (Revlon Professional, American Crew, CND) and a large owned-and-licensed fragrance business, now about a quarter of sales. Its brands are well known but under-invested. A decade of leveraged acquisitions, supply-chain failures and losses ended in a 2022–23 Chapter 11 reorganisation that handed control to credit funds. Under CEO Michelle Peluso since November 2024, the privately held group is running a brand-by-brand turnaround. The plan has three parts: sharpen brand identities (Revlon as "high-glam", Almay as clean drugstore makeup), expand aggressively in fragrance licensing, and rebuild the supply chain. Revenue has not been publicly reported since FY2022 ($1.98bn).
Company's own description (FY2022 10-K, Item 1). Revlon described itself as "a leading global beauty company with an iconic portfolio of brands." It said it develops, manufactures, markets, distributes and sells worldwide "an extensive array of beauty and personal care products." The list covered colour cosmetics, hair colour, hair care and treatments, fragrances, skin care, beauty tools, men's grooming, anti-perspirant deodorants and other beauty care, sold across a variety of channels. Its latest press boilerplate (Ice Spice launch release, 2026) describes it as "among the leading global beauty companies" with brands in colour cosmetics, skin care, hair colour, hair care and fragrance. The brands named are Revlon, Revlon Professional, Elizabeth Arden, Almay, Mitchum, American Crew, Creme of Nature, CND, Cutex, Juicy Couture, Elizabeth Taylor, Curve, John Varvatos, Christina Aguilera and Ice Spice.
Business model. Revlon is a branded consumer-packaged-goods manufacturer and marketer. Revenue is almost entirely product sales to retailers, distributors and salons. A small direct-to-consumer e-commerce stream runs through elizabetharden.com, americancrew.com, juicycouturebeauty.com and revlonprofessional.com. There is also a modest royalty stream: at 31 Dec 2022, eight licences of the Revlon trademark were in effect, covering more than 20 complementary product categories. No subscription or service revenue is disclosed. The fragrance business adds a licensing-in model. Revlon pays royalties to brand owners (Authentic Brands Group for Juicy Couture and Champion, celebrity licensors, Palm Angels) and also distributed about 27 third-party prestige fragrance brands (FY2022 10-K).
Revenue mix by product class (FY2022 10-K, Note 16). Colour cosmetics were 28% ($551.0M), fragrance 26% ($517.7M), hair care 23% ($451.9M), skin care 15% ($302.3M) and beauty care 8% ($157.5M).
Value-chain position. Revlon is vertically integrated from R&D through manufacturing to brand marketing. At FY2022 it had its own plants in the US (Oxford, North Carolina, its main and FDA-registered OTC drug facility; and Florida), Spain, Mexico, South Africa and Italy, supplemented by contract manufacturers in the US and Europe. Fragrance and some skin care rely more heavily on specialty third-party labs and manufacturers.
Customer types.
-
Mass retailers and drug chains: Walmart, CVS, Target, Walgreens, Kohl's, TJ Maxx/Marshalls.
-
Prestige and department stores: Macy's, Dillard's, Ulta, Belk, Sephora.
-
International chains: A.S. Watson, Boots, Superdrug, Shoppers Drug Mart, Douglas, Myer, The Perfume Shop.
-
Travel retail: Nuance, Heinemann, World Duty Free.
-
E-commerce platforms: Tmall in China.
-
Professional distributors: SalonCentric, Beauty Systems Group, Ulta Salon.
-
Individual salons and barbers.
Walmart and its affiliates were ~14% of net sales in both 2022 and 2021, and 18% in 2020.
End-markets. Mass colour cosmetics; mass hair colour; professional hair colour and care; men's grooming; professional nail (gel/Shellac); prestige skin care (notably China and travel retail for Elizabeth Arden); mass and prestige fragrance; deodorants (Mitchum).
Independent characterisation. Revlon is a sub-scale, multi-category beauty conglomerate. Its brand equity is greater than its financial capacity. Before bankruptcy it ran ~8,000 SKUs, many with 35–40 ingredients (Retail Dive, June 2022, citing CRO testimony). That complexity, combined with $3bn+ of debt, turned the 2021–22 supply shock into a liquidity crisis. The post-2023 model narrows priorities. Management is concentrating on fewer "right-to-win" brand positions, a fragrance licensing pipeline that is cheap to build and fast to launch, and supply-chain resilience. Mass shelf space (Walmart/Ulta/CVS) and China (Elizabeth Arden) remain the two most important commercial dependencies.
Strategy
Last filed strategy (FY2022 10-K). The company described three strategic pillars:
-
Strengthening its iconic brands through innovation and relevant product portfolios.
-
Building capabilities to communicate and connect with consumers where they spend the most time.
-
Ensuring availability of products where consumers shop, in-store and increasingly online.
These sat alongside the RGGA cost programme (rightsizing for profitability, cash flow and liquidity).
Current strategy (Peluso era, 2024–2026), as articulated in interviews (Glossy, Feb 2026; WWD/MEXC, Nov 2025):
-
Narrow, distinct brand identities. The approach is brand-by-brand demand mapping of where Revlon has a right to win. Revlon is repositioned to "high-glam, high-impact"; Peluso admitted past drift toward "no-makeup makeup". Almay is aimed at clean drugstore makeup. The PhotoReady relaunch (Feb 2026) targets Gen Z, and Peluso says the changes have already won more shelf space at some mass retailers.
-
Aggressive fragrance expansion. Fragrance is ~25% of sales. Initiatives include:
-
Ice Spice licence (launched 2026)
-
Christina Aguilera renewal (new scent 2026)
-
Juicy Couture renewal and new Just Moi formats
-
Champion (2027) and Palm Angels (2027) licences
-
Elizabeth Arden Eternal Aura (2026) Peluso called the Ice Spice deal "a major step in the revitalization of Revlon's fragrance business".
-
-
Supply-chain redesign. A "reframing" of the global supply chain and of China's role, including local R&D in China for Elizabeth Arden.
-
Data, digital and culture. A new CIDO and an emphasis on data-led consumer insight and accountability culture (WWD, Nov 2025).
-
R&D consolidation. The New Jersey lab moves to the NEST Center campus.
ESG / sustainability commitments. No post-2023 targets publicly disclosed.
Cost programmes. The pre-bankruptcy RGGA targeted up to $230M of annual savings by end-2022. Post-emergence cost targets are not publicly disclosed.
Medium-term targets and guidance. None published. As a private company Revlon issues no guidance. Bankruptcy-plan projections (2023 Disclosure Statement) existed but are now stale.
Products & Services
Pricing is not publicly disclosed at company level. Revlon describes its mass colour cosmetics as "principally priced in the upper range for large volume retailers" (FY2022 10-K).
Revlon segment
| Brand / line | Description & key capabilities | Target customer | Latest version / year | Flagship offerings |
|---|---|---|---|---|
| Revlon (colour cosmetics) | Face, lip, eye and nail makeup. Repositioned in 2025–26 as "high-glam, high-impact"; the CEO says it is "not a brand for 'no-makeup makeup'" (Glossy, Feb 2026) | Mass-market women; Gen Z targeted in relaunches | "Most Unforgettable Women in the World Wear Revlon" iteration of the "Be Unforgettable" campaign (Happi) | Super Lustrous lipstick |
| Revlon ColorStay | Long-wear technology across face, lip, eye and nail | Long-wear seekers | Ongoing | ColorStay foundation |
| Revlon PhotoReady | Photochromatic pigments for an airbrushed look | Gen Z / social-content creators | Relaunched Feb 2026 with new packaging, shades and formulas (Glossy) | PhotoReady face and eye |
| Revlon Age Defying | Face makeup for the over-35 bracket with anti-wrinkle ingredients | 35+ women | Ongoing | Age Defying foundation |
| Revlon Ultra HD | Liquid lip colour; one-coat vegan "20-free" nail colour | Mass | Ongoing | Ultra HD Matte Lip |
| Revlon So Fierce | Trend-forward eyeliner, mascara and shadow | Bold-look consumers | Ongoing | So Fierce eyeliner |
| Revlon ColorSilk | Mass at-home hair colour and care | Mass at-home colourers | Ongoing | ColorSilk Beautiful Color |
| Revlon Professional | Salon-exclusive hair colour, care and treatment in 85+ countries | Salon professionals | Color Excel by Revlonissimo Tone on Tone (ammonia-free demi-permanent) promoted 2026 (Behindthechair) | Revlonissimo, Eksperience, Nutri Color Creme, UniqOne, Equave |
| Revlon beauty tools | Nail, eye, skin and grooming tools, lash curlers, brushes | Mass | Ongoing | Tweezers, lash curlers |
| Revlon licensed products | 8 trademark licences across 20+ categories (FY2022) | Mass | Ongoing | Revlon-branded hair appliances (licensed category; licensee not named in filings) |
Elizabeth Arden segment
| Brand / line | Description | Target | Latest | Flagship |
|---|---|---|---|---|
| Ceramide | Barrier and anti-ageing skin care (capsules, retinol ceramide, eye) | Prestige 35+ | Retinol Ceramide line extensions (Beauty Packaging 2022/23) | Ceramide Capsules |
| Prevage | Idebenone-based anti-ageing (proprietary/patented technology per 10-K) | Prestige anti-ageing | Anti-Aging Eye Serum 2.0 | Prevage serum |
| Eight Hour | Multi-purpose balm franchise | Broad prestige | Ongoing | Eight Hour Cream |
| SUPERSTART | Skin-renewal boosters | Prestige | Ongoing | SUPERSTART booster |
| Visible Difference | Moisturisers | Prestige / masstige | Ongoing | Refining Moisture Cream |
| Skin Illuminating / Elizabeth Arden Pro | Brightening; professional channel | Prestige / spa | Ongoing | — |
| Red Door, 5th Avenue, White Tea, Green Tea, Always Red | Owned Arden fragrances; tea collections grew double-digit in 2021 | Prestige / masstige | Eternal Aura new scent planned for 2026 (Glossy) | Red Door, Green Tea |
| Arden colour cosmetics | Prestige makeup | Prestige | Ongoing | — |
| Virtual store | Immersive e-commerce store with Obsess (May 2023) | Digital shoppers | 2,023 | — |
China is a key growth market. Revlon set up a local R&D facility because Elizabeth Arden is a "powerhouse brand in China" (Peluso, Glossy, Feb 2026).
Portfolio segment
| Brand | Description | Target | Notes |
|---|---|---|---|
| Almay | Hypo-allergenic, fragrance-free cosmetics and removers (Smart Shade, Intense Eye Color, Color + Care) | Sensitive-skin / clean drugstore | CEO says Almay has a "right to win" in clean drugstore makeup (Glossy, 2026) |
| SinfulColors | Value nail enamels in bold colours | Value mass | — |
| Cutex | Nail polish remover and care | Mass | — |
| CND | Professional nail enhancement; Shellac 14+ day gel system; Vinylux weekly polish (light-curing, patent-pending); spa | Nail salons, 50+ countries | Shellac system relaunched with CND Visible Light lamp, which cures without UV or LED (Happi) |
| American Crew | Men's styling, care and shave for salons and barbers; "Official Supplier to Men"; 70+ countries plus DTC | Men / barbers | 2020 launches: Lather Shave Cream, Finishing Spray, Detox Shampoo |
| d:fi | Value unisex styling | Young mass | — |
| Mitchum | Anti-perspirant deodorants with patented 48-hour protection | Men and women, mass | — |
| Creme of Nature | Multicultural hair care (salon and retail), US-centred | Textured-hair consumers | Exposed to hair-relaxer litigation category (see Section 19) |
| Orofluido / Intercosmo | Professional hair care | Salons (Spain/Europe) | — |
| Llongueras (licensed) | Premium hair colour, Spain | Spanish mass | Licensed from a third party |
Fragrances segment (≈25% of company sales, 2026)
| Brand | Ownership | Positioning | Status |
|---|---|---|---|
| Juicy Couture (Just Moi, Viva la Juicy) | Licensed from Authentic Brands Group since 2016; renewed 2025 | Prestige / Gen Z | New Just Moi formats teased (Glossy, 2026) |
| Ice Spice "In Ha Mood" | Global licence; first Ice Spice fragrance | Gen Z celebrity | Launched 2026 at Ulta. Floral fruity amber EDP with "Queen Royale Accord" (berry fizz, pear, wild raspberry) and an emerald-cut cap (GCI / PR Newswire) |
| Christina Aguilera | Licence renewed (10+ year partnership: Signature, Definition, By Night) | Celebrity | New scent aimed at younger consumers in 2026 (GCI) |
| Elizabeth Taylor (White Diamonds) | Licensed / owned mark mix per 10-K | Heritage | Ongoing |
| Britney Spears | Licensed | Celebrity | Status after 2023 not confirmed in sources reviewed |
| John Varvatos | Licensed | Prestige men's | Ongoing |
| Champion | New global licence via Authentic Brands Group (2025) | Sport / lifestyle | First fragrance due 2027 |
| Palm Angels | New licence | Luxury streetwear | Scents due 2027 (Glossy) |
| Curve, Charlie, Halston, Giorgio Beverly Hills, Jean Naté, PS, Geoffrey Beene, Lucky Brand, Ed Hardy, Alfred Sung | Owned or licensed mass fragrance | Mass / value | Ongoing |
| AllSaints, Jennifer Aniston | Licensed | — | Licences rejected or expired by 31 Dec 2022 (FY2022 10-K) |
| Third-party distribution | ~27 prestige brands owned by others | Distribution | FY2022 |
Fragrance leadership: former Estée Lauder executive Amber Garrison leads the fragrance expansion (Clay company profile, 2026; corroborate with company sources).
Financial Narrative
Scope. The five most recent audited fiscal years publicly available are FY2018–FY2022. Full statement detail was retrieved for FY2019–FY2022 (FY2020 and FY2022 10-Ks). FY2018 revenue and net loss come from Revlon's reported comparatives. FY2023–FY2025: not publicly disclosed. The only post-emergence datapoints are Q1 2023 net sales of $490.0M (vs $479.6M in Q1 2022) and ~$1.5bn of debt at emergence (Reuters, May 2023). The Glossy (Feb 2026) reference to "just over $2 billion" relates to 2021.
Margins (%; calculated)
Revenue CAGR. FY2018–FY2022 was -6.3% a year; FY2019–FY2022 was -6.5% a year.
Commentary.
FY2019: Net sales fell 5.6% as the core Revlon colour business lost share to digitally native and celebrity brands. Operating income was barely positive ($60.7M), flattered by a $26.6M gain on divested assets.
FY2020: COVID cost an estimated $505M of sales. The year also carried a $144.1M impairment and a $158.8M tax charge, largely deferred-tax valuation allowances, which together produced a $619M loss. Within that, e-commerce rose ~40% to 16% of sales.
FY2021: The recovery year: sales +9.2% and gross margin at a peak of 59.2%. Interest of $247.7M still consumed more than twice operating income.
FY2022: Supply-chain shortages, $85.8M of FX headwind and $416.0M of reorganisation items produced the largest loss of the period. Adjusted EBITDA fell 11.1% to $260.3M.
The structural inflection is clear. Even in the best year, Adjusted EBITDA (≈$293M) only modestly exceeded cash interest (≈$242M paid in FY2021), so the capital structure, not the operations, set the outcome.
Balance sheet
FY2022 note: prepetition debt was reclassified into "liabilities subject to compromise" ($3,711.2M). FY2022 funded-debt and net-debt figures therefore cover mainly the DIP facilities and are not comparable with prior years. At filing the prepetition facilities included:
-
2016 Term Loan: $872.4M
-
2020 BrandCo facilities: $1,878.0M
-
Amended 2016 ABL / FILO / SISO: $289.0M
-
6.25% Senior Notes due 2024: $431.3M
(Source: FY2022 10-K, Item 1.)
Cash flow
The only equity outflows were tax withholding on RSU settlements: $1.6M (2019), $1.7M (2020), $2.4M (2021) and $3.3M (2022). FY2022 OCF also absorbed $152.0M of cash reorganisation items and a $61.2M inventory build.
Commentary. Revlon did not generate positive free cash flow in any of the four years. Cash interest of roughly $195–242M a year exceeded the gap between Adjusted EBITDA and working-capital needs. Capex was cut to ~0.5–0.7% of sales, below the 2–4% typical for beauty peers. That signals under-investment in the plants whose failures later contributed to the bankruptcy: Oxford, NC, Florida and Mexico facilities had closed or were weeks from closing for lack of supply at filing (Retail Dive, June 2022).
Ratios (calculated from 10-K data)
ROE and debt/equity are not meaningful because stockholders' equity was negative in every year. The FY2022 DPO collapse to 55 days reflects suppliers tightening terms ahead of and during the bankruptcy, the "deadly cycle" described in court filings. Post-emergence supplier data from Dun & Bradstreet show days-beyond-terms of 5–16 between Sep 2024 and Aug 2025, mostly below industry averages. Roughly 25%–37% of supplier payments were 1–30 days late in Jan–Aug 2025, with spikes in April (11) and May 2025 (16) (CosmeticsDesign, Oct 2025). This is a partial read on post-reorganisation liquidity discipline.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Principal channels |
|---|---|---|
Revlon | Revlon colour cosmetics (ColorStay, PhotoReady, Age Defying, Ultra HD, Super Lustrous, So Fierce), Revlon ColorSilk hair colour, Revlon Professional salon hair colour and care, Revlon beauty tools | Mass, drug, food, e-commerce, TV shopping, salons, ~150 countries |
Elizabeth Arden | Skin care (Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference, Skin Illuminating, Elizabeth Arden Pro), Arden fragrances (Red Door, 5th Avenue, White Tea, Green Tea, Always Red), colour cosmetics | Prestige, department stores, perfumeries, travel retail, Tmall/China, DTC |
Portfolio | Almay, SinfulColors, Cutex, CND (Shellac, Vinylux), American Crew, d:fi, Mitchum, Creme of Nature, Orofluido, Intercosmo, Llongueras (licensed, Spain) | Mass, salons, barbers, professional distributors |
Fragrances | Owned mass fragrances (Charlie, Curve, Giorgio Beverly Hills, Halston, Jean Naté, PS, White Diamonds) plus licensed prestige/celebrity brands (Juicy Couture, John Varvatos, Britney Spears, Christina Aguilera, Elizabeth Taylor, Ed Hardy, Lucky Brand, Alfred Sung, Geoffrey Beene) and ~27 third-party distributed brands | Prestige, mass, travel retail, e-commerce |
Revenue by Segment
| Segment | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Revlon segment net sales (USD Mn) | 958.8 | 688.4 | 727.9 | 752.6 |
Elizabeth Arden segment net sales (USD Mn) | 520.0 | 463.5 | 532.3 | 509.7 |
Portfolio segment net sales (USD Mn) | 487.8 | 401.3 | 419.1 | 373.4 |
Fragrances segment net sales (USD Mn) | 453.0 | 351.1 | 399.4 | 344.7 |
Total net sales (USD Mn) | 2,419.6 | 1,904.3 | 2,078.7 | 1,980.4 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Revlon segment profit (USD Mn) | 101.2 | 86.5 | 86.8 | 89.0 |
Elizabeth Arden segment profit (USD Mn) | 37.6 | 39.6 | 62.8 | 61.7 |
Portfolio segment profit (USD Mn) | 45.0 | 47.4 | 71.0 | 50.4 |
Fragrances segment profit (USD Mn) | 82.3 | 66.6 | 72.3 | 59.2 |
Total segment profit (USD Mn) | 266.1 | 240.1 | 292.9 | 260.3 |
Segment Margins & Growth (%)
| Segment | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Revlon margin (%) | 10.6 | 12.6 | 11.9 | 11.8 |
Elizabeth Arden margin (%) | 7.2 | 8.5 | 11.8 | 12.1 |
Portfolio margin (%) | 9.2 | 11.8 | 16.9 | 13.5 |
Fragrances margin (%) | 18.2 | 19.0 | 18.1 | 17.2 |
Group segment-profit margin (%) | 11.0 | 12.6 | 14.1 | 13.1 |
Segment Revenue
| Segment | FY2020 YoY (%) | FY2021 YoY (%) | FY2022 YoY (%) | FY2022 share of sales (%) |
|---|---|---|---|---|
Revlon | -28.2 | 5.7 | 3.4 | 38.0 |
Elizabeth Arden | -10.9 | 14.8 | -4.2 | 25.7 |
Portfolio | -17.7 | 4.4 | -10.9 | 18.9 |
Fragrances | -22.5 | 13.8 | -13.7 | 17.4 |
Income Statement
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Net sales (USD Mn) | 2,564.5 | 2,419.6 | 1,904.3 | 2,078.7 | 1,980.4 |
Net income (loss) (USD Mn) | -294.2 | -157.7 | -619.0 | -206.9 | -673.9 |
Income Statement and Per-Share Data
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Cost of sales (USD Mn) | 1,052.2 | 860.5 | 849.1 | 835.7 |
Gross profit (USD Mn) | 1,367.4 | 1,043.8 | 1,229.6 | 1,144.7 |
SG&A (USD Mn) | 1,316.6 | 1,071.8 | 1,099.1 | 1,033.1 |
Restructuring charges and other (USD Mn) | 12.8 | 49.7 | 26.1 | 6.5 |
Impairment charges (USD Mn) | 0.0 | 144.1 | 0.0 | 24.3 |
Operating income (loss) (USD Mn) | 60.7 | -226.3 | 103.2 | 79.9 |
Depreciation and amortisation (USD Mn) | 162.9 | 143.3 | 125.7 | 105.7 |
EBITDA, reported (op. income + D&A) (USD Mn) | 223.6 | -83.0 | 228.9 | 185.6 |
Adjusted EBITDA / total segment profit (USD Mn) | 266.1 | 240.1 | 292.9 | 260.3 |
Interest expense, net (USD Mn) | 196.6 | 243.3 | 247.7 | 252.9 |
Reorganisation items, net (USD Mn) | 0.0 | 0.0 | 0.0 | 416.0 |
Pre-tax income (loss), continuing ops (USD Mn) | -165.0 | -460.2 | -200.7 | -642.2 |
Income tax provision (USD Mn) | 0.2 | 158.8 | 6.2 | 31.7 |
Net income (loss) (USD Mn) | -157.7 | -619.0 | -206.9 | -673.9 |
Basic and diluted EPS (USD) | -2.97 | -11.59 | -3.84 | -12.28 |
Dividends per share (USD) | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Gross margin (%) | 56.5 | 54.8 | 59.2 | 57.8 |
Operating margin (%) | 2.5 | -11.9 | 5.0 | 4.0 |
Reported EBITDA margin (%) | 9.2 | -4.4 | 11.0 | 9.4 |
Adjusted EBITDA margin (%) | 11.0 | 12.6 | 14.1 | 13.1 |
Net margin (%) | -6.5 | -32.5 | -10.0 | -34.0 |
Balance Sheet
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Total assets (USD Mn) | 2,980.6 | 2,527.7 | 2,432.5 | 2,489.8 |
Cash and equivalents (USD Mn) | 104.3 | 97.1 | 102.4 | 249.3 |
Trade receivables (USD Mn) | 423.4 | 352.3 | 383.8 | 352.7 |
Inventories (USD Mn) | 448.4 | 462.6 | 417.4 | 469.3 |
Short-term debt incl. current LTD (USD Mn) | 290.2 | 220.0 | 137.9 | 747.1 |
Long-term debt (USD Mn) | 2,906.2 | 3,105.0 | 3,305.5 | 0.1 |
Total funded debt on balance sheet (USD Mn) | 3,196.4 | 3,325.0 | 3,443.4 | 747.2 |
Net debt (USD Mn) | 3,092.1 | 3,227.9 | 3,341.0 | 497.9 |
Liabilities subject to compromise (USD Mn) | 0.0 | 0.0 | 0.0 | 3,711.2 |
Stockholders' equity (deficiency) (USD Mn) | -1,221.2 | -1,862.0 | -2,014.1 | -2,662.7 |
Goodwill (USD Mn) | 673.7 | 563.7 | 562.8 | 562.2 |
Intangible assets, net (USD Mn) | 490.7 | 430.8 | 392.2 | 334.1 |
Goodwill and intangibles (USD Mn) | 1,164.4 | 994.5 | 955.0 | 896.3 |
Working capital (current assets less current liabilities) (USD Mn) | 154.5 | 202.2 | 252.0 | -48.5 |
Cash Flow
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Operating cash flow (USD Mn) | -68.3 | -97.3 | -11.0 | -243.5 |
Capital expenditures (USD Mn) | 29.0 | 10.3 | 14.2 | 13.8 |
Free cash flow (OCF less capex) (USD Mn) | -97.3 | -107.6 | -25.2 | -257.3 |
Permanent display purchases, within OCF (USD Mn) | 46.2 | 30.8 | 24.9 | 28.1 |
Cash interest paid (USD Mn) | 194.6 | 238.6 | 241.5 | 213.3 |
Dividends paid (USD Mn) | 0 | 0 | 0 | 0 |
Share buybacks (USD Mn) | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
ROA, net income / year-end assets (%) | -5.3 | -24.5 | -8.5 | -27.1 |
ROIC, op. income × (1-25% notional tax) / (net debt + equity) (%) | 2.4 | -12.4 | 5.8 | — |
Current ratio (x) | 1.16 | 1.24 | 1.32 | 0.96 |
Net debt / Adjusted EBITDA (x) | 11.6 | 13.4 | 11.4 | — |
Interest coverage, EBIT / interest (x) | 0.31 | -0.93 | 0.42 | 0.32 |
Adjusted EBITDA / interest (x) | 1.35 | 0.99 | 1.18 | 1.03 |
Asset turnover, sales / year-end assets (x) | 0.81 | 0.75 | 0.85 | 0.80 |
DSO (days) | 63.9 | 67.5 | 67.4 | 65.0 |
DIO (days, on cost of sales) | 155.5 | 196.2 | 179.4 | 205.0 |
DPO (days, on cost of sales) | 87.3 | 86.2 | 93.6 | 55.0 |
Cash conversion cycle (days) | 132.1 | 177.5 | 153.2 | 215.0 |
Revenue by Region
| Region | FY2020 | FY2022 |
|---|---|---|
North America net sales (USD Mn, ±1) | 986 | 973 |
EMEA net sales (USD Mn, ±1) | 434 | 470 |
Asia net sales (USD Mn, ±1) | 302 | 323 |
Latin America net sales (USD Mn) | 77.6 | 100.7 |
Pacific net sales (USD Mn) | 103.0 | 112.0 |
Total net sales (USD Mn) | 1,904.3 | 1,980.4 |
Segment Overview — Revlon
| Segment | North America | EMEA | Asia | Latin America | Pacific | Total |
|---|---|---|---|---|---|---|
Revlon | ~413 | ~166 | 37.9 | 66.5 | 68.4 | 752.6 |
Elizabeth Arden | 97.8 | ~123 | ~265 | 5.6 | 18.0 | 509.7 |
Portfolio | ~237 | ~103 | 2.2 | 16.9 | 13.3 | 373.4 |
Fragrances | 225.6 | 77.2 | 17.9 | 11.7 | 12.3 | 344.7 |
Valuation Snapshot
| Metric | Value |
|---|---|
Share price performance (1/3/5-year) | Not applicable (private). Historical: equity value went to zero under the Plan |
Last NYSE trading | 20 Oct 2022 (suspension) |
Shares outstanding at 31 Dec 2022 | 54,302,001 Class A |
Non-affiliate market value at 30 Jun 2022 | ~$43.7M |
P/E, EV/EBITDA, EV/Sales, P/B | Not applicable / not publicly disclosed |
Analyst consensus | None (no equity coverage) |
Dividends | None in FY2018–FY2022; none expected (Plan risk factors stated no dividends on new securities) |
Capital Markets Data
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Net sales (USD Mn) | 2,564.5 | 2,419.6 | 1,904.3 | 2,078.7 | 1,980.4 |
Capital Markets
| Item | Detail |
|---|---|
Moody's / S&P / Fitch ratings | Current corporate and facility ratings not publicly confirmed in sources reviewed. Pre-bankruptcy ratings were deep speculative grade, with S&P noting reliance on MacAndrews & Forbes support (Fortune, 2019) |
Debt at emergence | ~$1.5bn (Reuters, May 2023), comprising exit term loan and ABL facilities plus a $200M incremental new-money first-lien commitment (Debt Commitment Letter, Jan 2023) |
Liquidity at emergence | ~$236M |
Equity raised at emergence | $670M rights offering (backstopped) |
Pre-petition reference (FY2022 10-K) | 2016 Term Loan $872.4M; BrandCo $1,878.0M; ABL/FILO/SISO $289.0M; 6.25% Notes due 2024 $431.3M |
Analyst Conclusions
Management guidance. None published; Revlon is private and issues no guidance. Management's qualitative messages (Glossy, Feb 2026; WWD, Nov 2025) point to the "next chapter of growth" through fragrance expansion, sharper brand identities, a redesigned supply chain and a data-led culture.
Consensus growth expectations. None (no analyst coverage).
Bull case
-
Fragrance flywheel. Fragrance is already ~25% of sales and historically the highest-margin segment (17–19%). A pipeline of four new or renewed licences (Ice Spice 2026, Aguilera 2026, Champion 2027, Palm Angels 2027) plus Arden's Eternal Aura could mix group margins upward.
-
Fixed capital structure. With >$2.7bn of debt removed, FY2021-level Adjusted EBITDA (~$293M) would leave cash after interest for the brand investment Revlon could never afford, given capex of only 0.5–1.2% of sales historically.
-
Optionality on exit. Separable, recognisable assets (Elizabeth Arden in China, CND, American Crew, Juicy Couture fragrance) give credit-fund owners several monetisation routes.
Bear case
-
Mass colour remains structurally challenged. Revlon-brand North America sales fell >10% in 2018, and e.l.f., L'Oréal and private label continue to take share. The PhotoReady relaunch is a small step against much larger competitors.
-
Operational fragility persists. The CCC was 215 days (FY2022), supplier payments were still 25–37% late in early-to-mid 2025, and production is concentrated in a few plants. A new supply shock could again strain liquidity.
-
Leverage is still meaningful and opaque. At roughly 5.8x pre-improvement leverage with no public reporting, there is limited evidence the turnaround is earning out. Licence-driven fragrance growth can reverse if celebrity launches underperform.
Catalysts and monitorables (next 12 months)
-
Ice Spice "In Ha Mood" sell-through at Ulta and any expansion into international and mass distribution.
-
Christina Aguilera and Elizabeth Arden Eternal Aura launches (2026) and Champion and Palm Angels readiness (2027).
-
Evidence of shelf-space gains for the repositioned Revlon brand at Walmart, CVS and Ulta.
-
Any refinancing, ratings action or owner-led sale process. Credit funds' typical hold periods make a 2026–2028 exit plausible, though nothing has been announced.
-
Hair-relaxer MDL developments and any residual exposure for the reorganised entity.
-
Executive stability: CFO and CSTO tenure since 2023, and the board chair after Smith.
-
Completion of the R&D relocation to the NEST campus and China R&D output.
Analyst verdict. Revlon in 2026 is a credit-fund-owned turnaround of a heritage beauty franchise. Its last audited numbers (FY2022: $1.98bn sales, 57.8% gross margin, $260M Adjusted EBITDA, -$257M free cash flow) describe a company whose operations were sound enough to survive but whose capital structure was not. The 2023 reorganisation fixed the most urgent problem by cutting debt from roughly $3.4bn of funded borrowings to about $1.5bn. It did not by itself fix the operating gaps: under-investment, slow working capital, customer concentration and a fading mass-colour brand.
The Peluso agenda is credible and well sequenced. It starts with the cheapest, fastest lever, fragrance licensing, where Revlon has proven infrastructure and the highest historical segment margin. Next comes brand clarity for Revlon and Almay, aimed at recovering mass shelf space, alongside a supply chain rebuilt for resilience. The 2025–26 execution evidence is real but early: four licences signed or renewed, a PhotoReady relaunch, a national Ice Spice launch at Ulta and a strengthened executive bench. The financial evidence is largely absent. No revenue, EBITDA or leverage figure has been published since 2022, and supplier-payment data show a company that is managing liquidity rather than enjoying a surplus.
On balance, Revlon looks like a stabilised, modestly improving business. Its value depends on whether the fragrance-led mix shift can lift Adjusted EBITDA margins sustainably above the ~13–14% achieved in FY2021–22, and whether its owners can then refinance or exit at a valuation that repays their conversion of debt into equity. For counterparties (suppliers, licensors, retailers), we judge credit risk elevated but much lower than in 2022. For prospective acquirers, the most attractive pieces are probably Elizabeth Arden (China skin care), CND and the fragrance licence book rather than the namesake mass colour business. Our view is cautiously constructive on direction and low-confidence on magnitude until the company resumes financial disclosure.
Principal sources
-
Revlon, Inc. Form 10-K FY2022 (filed 17 Mar 2023) and XBRL R-pages R3, R5, R9, R33, R57 — SEC EDGAR CIK 887921
-
Revlon, Inc. Form 10-K FY2020 (filed 11 Mar 2021) and XBRL R2, R4, R8, R46
-
Revlon Q4/FY2022 results release (Business Wire, 15 Mar 2023)
-
Reuters, "Revlon emerges from bankruptcy after lender takeover" (2 May 2023); ABL Advisor, FashionUnited, Cosmetics Business, Beauty Packaging emergence coverage (May 2023)
-
Retail Dive (Revlon hires Peluso, Oct 2024; supply-chain bankruptcy, Jun 2022; RSA, Mar 2023; sale exploration, 2019)
-
FashionNetwork (Peluso appointment, Oct 2024; Marshall CIDO, Mar 2025; refinancing, May 2020)
-
FashionUnited (Medema, Apr 2025)
-
Happi top-company profile (Revlon); Happi (Aug 2023 executive hires; Ice Spice licence)
-
Glossy, "3 standout strategies driving Revlon's 2026 comeback plan" (23 Feb 2026)
-
GCI Magazine / Cosmetics & Toiletries company pages (Champion, Aguilera, Juicy Couture, NEST lab); GCI / PR Newswire (Ice Spice "In Ha Mood" launch, 2026)
-
CosmeticsDesign, "Financial Focus: Revlon's path to revival" (23 Oct 2025)
-
Gulf News/Reuters, City A.M., Business of Fashion (Elizabeth Arden deal, 2016); Fortune and Industry Week (2019 strategic review)
-
Behindthechair (Revlon Professional Color Excel, 2026); Snov.io and Clay company profiles (2026; used only for low-weight context)
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Since | Prior roles | Education / age |
|---|---|---|---|---|
Michelle Peluso | Chief Executive Officer; board member | 4 Nov 2024 | CVS Health EVP and Chief Customer & Experience Officer (also described as co-president, CVS Pharmacy); Global CMO at IBM and Citi; CEO of Travelocity and Gilt; Nike board director | — |
Ted McCormick | Chief Financial Officer | 5 Sep 2023 | CFO RealTruck (2021–23); CFO The Bountiful Company (sold by KKR to Nestlé); ~two decades at Unilever, including CFO of Ben & Jerry's and the Pepsi Lipton Partnership | Not disclosed. Still in role as of latest sources? Not re-confirmed in 2026 |
Will Cornock | Chief Strategy & Transformation Officer | 5 Sep 2023 | Partner, Boston Consulting Group | Not disclosed. Current status not re-confirmed |
Dana Medema | President, North America | 5 May 2025 | SVP and Head of Personal Health North America, Philips; ~20 years at Colgate-Palmolive | — |
Ralph Marshall | Chief Information & Digital Officer | 1 Apr 2025 | Global CTO, Merlin Entertainments; VP Technology EMEA, Starbucks; McDonald's IT Europe | — |
David Schwartz | General Counsel | Appointed in a February (year not specified in Happi profile; likely 2025) | — | — |
Amber Garrison | Head of fragrance expansion (title not confirmed) | 2025–2026 (approx.) | Former Estée Lauder executive | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Aug 2023 | Debra Perelman steps down as CEO; Liz Smith interim CEO | Ended Perelman-family management after emergence |
5 Sep 2023 | McCormick (CFO), Breig (President NA), Cornock (CSTO) join | Post-bankruptcy professionalisation |
4 Nov 2024 | Michelle Peluso becomes CEO | Permanent CEO after more than a year of interim leadership |
1 Apr 2025 | Ralph Marshall replaces CIO Paul Smith as CIDO | Digital and data capability (Peluso: "make sure we've got the data right") |
5 May 2025 | Dana Medema replaces Geralyn Breig as President NA | Breig credited with the post-bankruptcy North America turnaround |
Feb (2025, approx.) | David Schwartz appointed General Counsel | — |
Major Shareholders
| Holder | Stake |
|---|---|
Glendon Capital Management | Not publicly disclosed (lead owner group member) |
Competitive Landscape
Competitors by Segment
| Segment | Direct competitors |
|---|---|
Mass colour (Revlon, Almay) | L'Oréal (Maybelline, L'Oréal Paris, NYX), Coty (CoverGirl, Rimmel, Max Factor), e.l.f. Beauty, Markwins, private label |
Hair colour and care | L'Oréal (Excellence, L'Oréal Professionnel), Henkel (Schwarzkopf), Coty (Wella stake), Kao (Goldwell), Unilever |
Prestige skin care (Elizabeth Arden) | Estée Lauder, Shiseido, L'Oréal Luxe, AmorePacific, LG H&H, Beiersdorf |
Professional nail (CND) | Hand & Nail Harmony (Gelish), OPI (Wella), Kiara Sky |
Men's grooming (American Crew) | L'Oréal, Henkel, P&G, Unilever |
Fragrance | Coty, Puig, Interparfums, L'Oréal Luxe, Estée Lauder, Parlux, Elizabeth Arden peers in celebrity fragrance |
Deodorant (Mitchum) | P&G (Secret, Old Spice), Unilever (Dove, Degree), Beiersdorf (Nivea) |
Digital-native challengers | Fenty Beauty, Kylie Cosmetics, Glossier, Anastasia Beverly Hills, Too Faced, Benefit |
Peer Comparison FY2025
| Metric | Revlon (FY2022) | L'Oréal (FY2024) | Coty (FY2025, June YE) | e.l.f. Beauty (FY2025, March YE) |
|---|---|---|---|---|
Revenue | $1.98bn | ~€43.5bn | ~$5.9bn | ~$1.3bn |
Revenue growth | -4.7% | ~+5.6% | ~-4% | ~+28% |
Gross margin | 57.8% | ~74% | ~64% | ~71% |
Adj. EBITDA / operating margin | 13.1% adj. EBITDA | ~20% operating | ~17–18% adj. EBITDA | ~22% adj. EBITDA |
R&D intensity | Not disclosed (~200 R&D staff) | ~3% of sales | ~1–2% (approx.) | Not material / not disclosed |
Recent Developments
As a private company Revlon publishes limited news. Items with uncertain exact dates are marked "approx."



